2-(2,3-DIHYDRO-BENZO[1,4]DIOXINE-6-SULFONYLAMINO)-BUTYRIC ACID
![]() |
- $378 - $874
- Product name: 2-(2,3-DIHYDRO-BENZO[1,4]DIOXINE-6-SULFONYLAMINO)-BUTYRIC ACID
- CAS: 301301-44-0
- MF: C12H15NO6S
- MW: 301.32
- EINECS:
- MDL Number:MFCD00706443
- Synonyms:TIMTEC-BB SBB012315;2-(2,3-DIHYDRO-BENZO[1,4]DIOXINE-6-SULFONYLAMINO)-BUTYRIC ACID;Butanoic acid, 2-[[(2,3-dihydro-1,4-benzodioxin-6-yl)sulfonyl]amino]-;2-(2,3-Dihydrobenzo[b][1,4]dioxine-6-sulfonamido)butanoic acid
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500MG
- 1g
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0087673
- Product description2-(2,3-DIHYDRO-BENZO[1,4]DIOXINE-6-SULFONYLAMINO)-BUTYRIC ACID 95.00%
- Packaging500MG
- Price$768.08
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11151078
- Product description2-(2,3-Dihydrobenzo[b][1,4]dioxine-6-sulfonamido)butanoicacid 97%
- Packaging5g
- Price$874
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number010879
- Product description2-(2,3-Dihydro-benzo[1,4]dioxine-6-sulfonylamino)-butyric acid
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0087673 | 2-(2,3-DIHYDRO-BENZO[1,4]DIOXINE-6-SULFONYLAMINO)-BUTYRIC ACID 95.00% | 500MG | $768.08 | 2021-12-16 | Buy |
Crysdot | CD11151078 | 2-(2,3-Dihydrobenzo[b][1,4]dioxine-6-sulfonamido)butanoicacid 97% | 5g | $874 | 2021-12-16 | Buy |
Matrix Scientific | 010879 | 2-(2,3-Dihydro-benzo[1,4]dioxine-6-sulfonylamino)-butyric acid | 1g | $378 | 2021-12-16 | Buy |
Properties
Boiling point :503.3±60.0 °C(Predicted)
Density :1.411±0.06 g/cm3(Predicted)
pka :3.35±0.10(Predicted)
Density :1.411±0.06 g/cm3(Predicted)
pka :3.35±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|